Validation and Assessment of Novel Morphology-Voltage-P-wave Score for Diagnosing Left Ventricular Diastolic Dysfunction in Patients With Hypertension

ConditionHypertension
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorUniversitas Diponegoro

About this trial

This study aimed to assess and validate the diagnostic utility of a novel Morphology-Voltage-P-wave Score (MVP Score) in identifying left ventricular diastolic dysfunction among patients with hypertension.

Researchers will collect information of patient with hypertension and underwent transthoracal echocardiography assessment. The data consist of demographic data, clinical presentation, laboratory, and echocardiography result were collected by two investigators. Then, the data was analyzed by using IBM SPSS Statistics v26.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Essential hypertension

Disqualifiers

Secondary or resistant hypertension

LVEF<55%

Congenital heart disease

Infiltrative cardiomyopathy

Trial population

Patient with essential hypertension who came to out hospital

Trial design

Design model

Case-control

Time perspective

Cross-sectional

Treatments tested in this trial

  • Echocardiohraphy

    Diagnostic test

    Transthoracal echocardiography for diastolic function assessment

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: Patient with LVDD1 intervention
Group B: Patient without LVDD1 intervention

Trial outcomes

Primary outcomes

1

Diastolic Dysfunction

Diastolic Dysfunction found in transthoracal echocardiography assessment

Time frame
Up to 1 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.